Innovations in the Management of Neuroendocrine Tumors, an Issue of Endocrinology and Metabolism Clinics of North America, 1e (The Clinics: Internal Medicine) (in English)
Innovations in the Management of Neuroendocrine Tumors, an Issue of Endocrinology and Metabolism Clinics of North America, 1e (The Clinics: Internal Medicine) (in English)
Innovations in the Management of Neuroendocrine Tumors, an Issue of Endocrinology and Metabolism Clinics of North America, 1e (The Clinics: Internal Medicine) (in English) - Ashley B. Grossman Ba Bsc Md Frcp Fmedsc
Physical Book
$ 120.88
$ 201.46
You save: $ 80.58
40% discount
Envío gratis a todo Estados Unidos
Choose the list to add your product or create one New List
Origin: United Kingdom
(Import costs included in the price)
It will be shipped from our warehouse between Wednesday, July 17 and Monday, July 29.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Innovations in the Management of Neuroendocrine Tumors, an Issue of Endocrinology and Metabolism Clinics of North America, 1e (The Clinics: Internal Medicine) (in English)
Ashley B. Grossman Ba Bsc Md Frcp Fmedsc
Synopsis "Innovations in the Management of Neuroendocrine Tumors, an Issue of Endocrinology and Metabolism Clinics of North America, 1e (The Clinics: Internal Medicine) (in English)"
This issue of Endocrinology and Metabolism Clinics, edited by Dr. Ashley Grossman, will focus on Innovations in the Management of Neuroendocrine Tumors. Topics include, but are not limited to, Molecular targeted therapy of NETs – State of the art; Surgical approaches to the management of liver metastases; Liquid biopsies for NETs – circulating tumour cells and DNA; Novel functional imaging of NETs; The problem of appendiceal carcinoids; Peptide radioreceptor therapy comes of age; Current chemotherapy use in NETs; The problem of grade 3 NETs; Molecular genetic studies of pancreatic neuroendocrine tumours reveal new therapeutic approaches; The new WHO classification; Gastrinomas – medical or surgical treatment; When and how to use somatostatin analogues; The NETest as the way forward; Lung and thymic carcinoids; Carcinoid heart disease; Gastric carcinoids; New treatments for the carcinoid syndrome; and The genesis of the NETs concept – From Oberdorfer to 2018.